Search

Search Results

• 

  Membranous nephropathy in a patient with Sjögren’s disease

  Kubra Kaynar, Şeymanur Serdar Kılıçaslan, Sevdegül Mungan, Seda Akduman, Vildan Kumcu, Nihan Yazıcı

  20-05-2025

  https://doi.org/10.4081/reumatismo.2025.1794

  720

  PDF: 226

• Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

  U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

  268-274

  https://doi.org/10.4081/reumatismo.2006.268

  1531

  PDF: 2662
• 

  The vicious cycle of physical inactivity, fatigue and kinesiophobia in patients with fibromyalgia syndrome

  B. Cigdem Karacay, T. Sahbaz, C. Medin Ceylan

  21-03-2023

  https://doi.org/10.4081/reumatismo.2022.1502

  1675

  PDF: 917

• B Lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis

  L. Quartuccio, M. Fabris, G. Ferraccioli

  143-146

  https://doi.org/10.4081/reumatismo.2004.143

  1455

  PDF: 1054

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  https://doi.org/10.4081/reumatismo.2009.132

  1901

  PDF: 1128

• Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis?

  M.A. Cimmino

  245-252

  https://doi.org/10.4081/reumatismo.2006.245

  856

  PDF: 2284

• Recombinant adenovirus-mediated gene transfer suppresses experimental arthritis

  E. Quattrocchi, M. Feldmann

  46-54

  https://doi.org/10.4081/reumatismo.2001.46

  679

  PDF: 709

• The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects

  A. Corrado, F.P. Cantatore

  142-153

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.142

  881

  PDF: 1890

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  https://doi.org/10.4081/reumatismo.2010.215

  1178

  PDF: 790

• Epidemiology and risk factors in osteoarthritis: literature review data from “OASIS” study

  L. De Filippis, S. Gulli, A. Caliri, C. Romano, F. Munaò, G. Trimarchi, D. La Torre, C. Fichera, A. Pappalardo, G. Triolo, M. Gallo, G. Valentini, G. Bagnato, Gruppo OASIS (Osteoarthritis South Italy Study)

  169-184

  https://doi.org/10.4081/reumatismo.2004.169

  4308

  PDF: 11239

• TNFα blockers and infectious risk in rheumatoid arthritis

  B. Raffeiner, C. Botsios, F. Ometto, L. Bernardi, A. Montante, P. Sfriso, S. Todesco, L. Punzi

  165-173

  https://doi.org/10.4081/reumatismo.2009.165

  1628

  PDF: 2106

• The treatment of skin ulcers in patients with systemic sclerosis

  G. Fiori, L. Amanzi, A. Moggi Pignone, F. Braschi, M. Matucci- Cerinic

  225-234

  https://doi.org/10.4081/reumatismo.2004.225

  1376

  PDF: 3534

• Tenosynovitis of the ankles as onset of sarcoidosis in a patient with ulcerative colitis

  A. Furlan, M. Podswiadek, F. Cozzi, S. Todesco

  197-200

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.197

  1390

  PDF: 1408

• Hypocomplementemia in systemic sclerosis

  M. Hudson, R. Steele, Y. Lu

  156-157

  https://doi.org/10.4081/reumatismo.2009.156

  837

  PDF: 523
• 

  Impact of ultrasonography detected quadriceps calcific tendinopathy on pain and function in patients with primary knee osteoarthritis

  M.A. Mortada, L.I. Kotb, Y.A. Amer

  111-116

  03-08-2021

  https://doi.org/10.4081/reumatismo.2021.1381

  3175

  PDF: 713

• Enzymes and muscle diseases

  M. Plebani

  158-165

  https://doi.org/10.4081/reumatismo.2001.158

  1180

  PDF: 2098

• Detection of serum anti-B/B’ UsnRNP antibodies in patients with connective tissue diseases by immunoblotting

  A. Ghirardello, A. Doria, S. Zampieri, D. Villalta, R. Tozzoli, L. Iaccarino, R. Bendo, P.F. Gambari

  324-330

  https://doi.org/10.4081/reumatismo.2002.324

  883

  PDF: 2668

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1014

  PDF: 982

• Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine

  L. Cavagna, P. Rossi, L. Bogliolo, E. Antoniazzi, C. Gelmi, R. Caporali, C. Montecucco

  226-231

  https://doi.org/10.4081/reumatismo.2002.226

  2302

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  https://doi.org/10.4081/reumatismo.2004.1s.62

  1267

  PDF: 1907
• 

  Top 100 cited articles on ankylosing spondylitis

  F. Bagcier, O.V. Yurdakul, E. Ozduran

  218-227

  18-01-2021

  https://doi.org/10.4081/reumatismo.2020.1325

  1886

  PDF: 1000

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  744

  PDF: 674

• Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides

  N. Bizzaro, M. Tampoia

  222-228

  https://doi.org/10.4081/reumatismo.2009.222

  1062

  PDF: 851
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  1785

  PDF: 430

• Hyper-IgD syndrome and hereditary periodic fever syndromes

  R. Scolozzi, A. Boccafogli, L. Vicentini

  147-155

  https://doi.org/10.4081/reumatismo.2004.147

  1167

  PDF: 3312

• Systemic lupus erythematosus: the first italian prevalence study

  M. Benucci, F. Li Gobbi, A. Del Rosso, M. Manfredi

  103-108

  https://doi.org/10.4081/reumatismo.2005.103

  1270

  PDF: 1390

• Seronegative spondyloarthropathies and allergic diseases in patients with ulcerative colitis

  F. Manguso, A. D’Arienzo, C. Astarita, F.P. D’Armiento, D. Gargano, R. Peluso, T. Staiano, F. Ayala, G. Mazzacca, R. Scarpa

  27-35

  https://doi.org/10.4081/reumatismo.2002.27

  931

  PDF: 664

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  3-7

  https://doi.org/10.4081/reumatismo.2005.4s.3

  1162

  PDF: 739